Oncothyreon And Celldex Therapeutics Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 and Varlilumab
November 10, 2014 at 16:10 PM EST
Oncothyreon Inc. (Nasdaq: ONTY) and Celldex Therapeutics, Inc., (Nasdaq: CLDX) today announced that they have initiated a combined ...